Li Nanfang, Zhu Qing, Dang Yujie, Zhou Yin, Cai Xintian, Heizhati Mulalibieke, Zhang Delian, Yao Xiaoguang, Luo Qin, Hu Junli, Wang Guoliang, Wang Yingchun, Wang Menghui, Hong Jing
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region; Xinjiang Hypertension Institute; National Health Committee Key Laboratory of Hypertension Clinical Research; Key Laboratory of Xinjiang Uygur Autonomous Region "Hypertension Research Laboratory"; Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, 830001 Urumqi, Xinjiang, China.
Medical Department, Yidu Cloud (Beijing) Technology Co., Ltd., 100191 Beijing, China.
Rev Cardiovasc Med. 2024 Mar 12;25(3):104. doi: 10.31083/j.rcm2503104. eCollection 2024 Mar.
The accurate identification and diagnosis of secondary hypertension is critical,especially while cardiovascular heart disease continues to be the leading cause of death. To develop a big data intelligence platform for secondary hypertension using electronic medical records to contribute to future basic and clinical research.
Using hospital data, the platform, named Hypertension DATAbase at Urumchi (UHDATA), included patients diagnosed with hypertension at the People's Hospital of Xinjiang Uygur Autonomous Region since December 2004. The electronic data acquisition system, the database synchronization technology, and data warehouse technology (extract-transform-load, ETL) for the scientific research big data platform were used to synchronize and extract the data from each business system in the hospital. Standard data elements were established for the platform, including demographic and medical information. To facilitate the research, the database was also linked to the sample database system, which includes blood samples, urine specimens, and tissue specimens.
From December 17, 2004, to August 31, 2022, a total of 295,297 hypertensive patients were added to the platform, with 53.76% being males, with a mean age of 59 years, and 14% with secondary hypertension. However, 75,802 patients visited the Hypertension Center at our hospital, with 43% (32,595 patients) being successfully diagnosed with secondary hypertension. The database contains 1458 elements, with an average fill rate of 90%. The database can continuously include the data for new hypertensive patients and add new data for existing hypertensive patients, including post-discharge follow-up information, and the database updates every 2 weeks. Presently, some studies that are based on the platform have been published.
Using computer information technology, we developed and implemented a big database of dynamically updating electronic medical records for patients with hypertension, which is helpful in promoting future research on secondary hypertension.
继发性高血压的准确识别与诊断至关重要,尤其是在心血管疾病仍是主要死因的情况下。利用电子病历开发一个用于继发性高血压的大数据智能平台,以助力未来的基础和临床研究。
利用医院数据,该名为乌鲁木齐高血压数据库(UHDATA)的平台纳入了自2004年12月起在新疆维吾尔自治区人民医院被诊断为高血压的患者。科研大数据平台的电子数据采集系统、数据库同步技术和数据仓库技术(提取-转换-加载,ETL)被用于同步和提取医院各业务系统的数据。为该平台建立了标准数据元素,包括人口统计学和医疗信息。为便于研究,该数据库还与样本数据库系统相链接,后者包括血液样本、尿液标本和组织标本。
从2004年12月17日至2022年8月31日,该平台共纳入295,297例高血压患者,其中男性占53.76%,平均年龄59岁,继发性高血压患者占14%。然而,75,802例患者到我院高血压中心就诊,其中43%(32,595例患者)被成功诊断为继发性高血压。该数据库包含1458个元素,平均填充率为90%。该数据库可不断纳入新高血压患者的数据,并为现有高血压患者添加新数据,包括出院后随访信息,且数据库每两周更新一次。目前,一些基于该平台的研究已发表。
利用计算机信息技术,我们开发并实施了一个用于高血压患者的动态更新电子病历大型数据库,这有助于推动未来对继发性高血压的研究。